HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Depo-Provera in the treatment of recurrent vulvovaginal candidiasis.

Abstract
The long-acting injectable progestogen Depo-Provera appears to substantially reduce women's susceptibility to recurrent vulvovaginal candidiasis. Pregnancy and exogenous estrogen appear to counteract this effect of the drug. Evidence was derived from 15 patients studied for up to six years.
AuthorsG J Dennerstein
JournalThe Journal of reproductive medicine (J Reprod Med) Vol. 31 Issue 9 Pg. 801-3 (Sep 1986) ISSN: 0024-7758 [Print] United States
PMID2945926 (Publication Type: Journal Article)
Chemical References
  • Medroxyprogesterone Acetate
  • Medroxyprogesterone
Topics
  • Adult
  • Candidiasis (drug therapy)
  • Female
  • Humans
  • Injections, Intramuscular
  • Medroxyprogesterone (analogs & derivatives, therapeutic use)
  • Medroxyprogesterone Acetate
  • Recurrence
  • Vaginal Diseases (drug therapy)
  • Vulvar Diseases (drug therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: